Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA-mBN85B Measles Vaccine in Healthy Children
NCT00891007Phase 2Completed
- Sponsor
- Bavarian Nordic
- Start
- Jun 2009
- Primary completion
- Jul 2010
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of MVA-mBN85B in measles, sponsored by Bavarian Nordic. Started Jun 2009; status: completed.
02
Drugs
MVA-mBN85B
03
Conditions
measles
Beyond the preview
Go deeper on NCT00891007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00891007.